Business Description
Access Bio Inc
NAICS : 621511
SIC : 8071
ISIN : KR8840090003
Share Class Description:
XKRX:950130: Korean Depository ReceiptsCompare
Compare
Traded in other countries / regions
950130.Korea IPO Date
2013-05-30Description
Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.74 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.13 | |||||
| Debt-to-EBITDA | 5.71 | |||||
| Interest Coverage | 5.66 | |||||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | 3.64 | |||||
| Beneish M-Score | -0.96 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 41.7 | |||||
| 3-Year EBITDA Growth Rate | -41.3 | |||||
| 3-Year Book Growth Rate | 94.5 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 80.55 | |||||
| 9-Day RSI | 67.21 | |||||
| 14-Day RSI | 56.69 | |||||
| 6-1 Month Momentum % | -25.08 | |||||
| 12-1 Month Momentum % | -25.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.51 | |||||
| Quick Ratio | 8.77 | |||||
| Cash Ratio | 7.88 | |||||
| Days Inventory | 130.38 | |||||
| Days Sales Outstanding | 65.4 | |||||
| Days Payable | 3.8 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 1.8 | |||||
| Shareholder Yield % | 10.74 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 48.69 | |||||
| Operating Margin % | 6.08 | |||||
| Net Margin % | -1.13 | |||||
| FCF Margin % | -35.65 | |||||
| ROE % | -0.63 | |||||
| ROA % | -0.48 | |||||
| ROIC % | 5.61 | |||||
| ROC (Joel Greenblatt) % | -1.86 | |||||
| ROCE % | -0.46 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 4.53 | |||||
| PS Ratio | 0.72 | |||||
| PB Ratio | 0.39 | |||||
| Price-to-Tangible-Book | 0.4 | |||||
| EV-to-EBIT | 12.32 | |||||
| EV-to-EBITDA | -3.03 | |||||
| EV-to-Revenue | -0.11 | |||||
| EV-to-FCF | 0.32 | |||||
| Price-to-Projected-FCF | 0.19 | |||||
| Price-to-Median-PS-Value | 0.25 | |||||
| Price-to-Net-Current-Asset-Value | 0.74 | |||||
| Price-to-Net-Cash | 0.97 | |||||
| Earnings Yield (Greenblatt) % | 8.12 | |||||
| FCF Yield % | -52.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Access Bio Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 343,731.496 | ||
| EPS (TTM) (â‚©) | -200 | ||
| Beta | 0.24 | ||
| Volatility % | 67.29 | ||
| 14-Day RSI | 56.69 | ||
| 14-Day ATR (â‚©) | 220.037507 | ||
| 20-Day SMA (â‚©) | 6536.5 | ||
| 12-1 Month Momentum % | -25.82 | ||
| 52-Week Range (â‚©) | 6250 - 14340 | ||
| Shares Outstanding (Mil) | 33.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Access Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Access Bio Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Access Bio Inc Frequently Asked Questions
What is Access Bio Inc(XKRX:950130)'s stock price today?
The current price of XKRX:950130 is â‚©6860.00. The 52 week high of XKRX:950130 is â‚©14340.00 and 52 week low is â‚©6250.00.
When is next earnings date of Access Bio Inc(XKRX:950130)?
The next earnings date of Access Bio Inc(XKRX:950130) is .
Does Access Bio Inc(XKRX:950130) pay dividends? If so, how much?
Access Bio Inc(XKRX:950130) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers